Janney Montgomery Scott LLC Candel Therapeutics, Inc. Transaction History
Janney Montgomery Scott LLC
- $38.3 Billion
- Q2 2025
A detailed history of Janney Montgomery Scott LLC transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 27,290 shares of CADL stock, worth $173,291. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,290
Previous 21,090
29.4%
Holding current value
$173,291
Previous $119,000
15.97%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CADL
# of Institutions
84Shares Held
15.7MCall Options Held
536KPut Options Held
335K-
Baker Bros. Advisors LP New York, NY2.44MShares$15.5 Million0.16% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.15MShares$13.7 Million8.46% of portfolio
-
Northpond Ventures, LLC1.94MShares$12.3 Million48.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.79MShares$11.4 Million0.0% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.62MShares$10.3 Million0.59% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $183M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...